Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BSGM | BioSig Technologies, Inc.

Index- P/E- EPS (ttm)-0.56 Insider Own7.80% Shs Outstand70.28M Perf Week27.03%
Market Cap41.45M Forward P/E- EPS next Y-0.29 Insider Trans0.67% Shs Float63.53M Perf Month18.40%
Income-31.90M PEG- EPS next Q-0.09 Inst Own9.50% Short Float / Ratio4.02% / 3.39 Perf Quarter-49.25%
Sales0.30M P/S138.15 EPS this Y32.90% Inst Trans0.64% Short Interest2.56M Perf Half Y-47.12%
Book/sh0.00 P/B- EPS next Y34.10% ROA-693.80% Target Price4.05 Perf Year-11.37%
Cash/sh0.02 P/C29.60 EPS next 5Y- ROE- 52W Range0.25 - 1.65 Perf YTD49.83%
Dividend- P/FCF- EPS past 5Y12.60% ROI- 52W High-61.86% Beta1.30
Dividend %- Quick Ratio0.50 Sales past 5Y- Gross Margin79.30% 52W Low150.32% ATR0.07
Employees47 Current Ratio0.60 Sales Q/Q- Oper. Margin- RSI (14)56.55 Volatility12.18% 13.43%
OptionableYes Debt/Eq0.00 EPS Q/Q-7.10% Profit Margin- Rel Volume0.80 Prev Close0.57
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume754.17K Price0.63
Recom2.00 SMA2024.28% SMA50-12.20% SMA200-34.73% Volume603,520 Change10.21%
Date Action Analyst Rating Change Price Target Change
Mar-30-20Initiated ROTH Capital Buy $9
Aug-25-23 09:34AM
Aug-24-23 10:30AM
Aug-23-23 08:30AM
Aug-22-23 08:00AM
Jul-25-23 08:30AM
07:11AM Loading…
Jul-20-23 07:11AM
Jun-29-23 11:52AM
Jun-27-23 08:30AM
May-25-23 09:00AM
May-19-23 07:30AM
May-03-23 09:00AM
Mar-27-23 08:38AM
Mar-24-23 08:30AM
Mar-13-23 07:30AM
07:30AM Loading…
Feb-22-23 07:30AM
Feb-17-23 07:30AM
Feb-07-23 08:00AM
Jan-19-23 08:30AM
Jan-10-23 08:30AM
Dec-14-22 04:30PM
Dec-06-22 08:30AM
Oct-24-22 11:03AM
Oct-12-22 10:00AM
Oct-07-22 09:35AM
Sep-22-22 09:00AM
Sep-16-22 09:30AM
Sep-09-22 07:15AM
12:33PM Loading…
Sep-08-22 12:33PM
Aug-30-22 09:37AM
Aug-24-22 09:17AM
Aug-17-22 09:15AM
Aug-16-22 09:47AM
Jul-21-22 10:00AM
Jul-07-22 08:30AM
Jun-29-22 05:45PM
Jun-24-22 09:30AM
Jun-23-22 04:26PM
Jun-22-22 08:00AM
May-31-22 09:25AM
May-26-22 09:08AM
May-25-22 09:47AM
May-12-22 05:55PM
May-11-22 08:30AM
May-05-22 06:55PM
May-04-22 07:55AM
Apr-19-22 09:10AM
Apr-07-22 08:30AM
Mar-29-22 10:06AM
Mar-23-22 08:00AM
Mar-22-22 08:00AM
Mar-16-22 09:00AM
Feb-08-22 01:38PM
Jan-26-22 01:00PM
Jan-07-22 10:20AM
Jan-06-22 08:30AM
Dec-21-21 09:00AM
Dec-16-21 09:15AM
Dec-13-21 08:30AM
Dec-06-21 10:00AM
Dec-01-21 09:25AM
Nov-17-21 09:45AM
Nov-16-21 09:52AM
Nov-11-21 02:45PM
Nov-10-21 09:20AM
Nov-08-21 11:30AM
Nov-04-21 11:00AM
Nov-01-21 12:30PM
Oct-13-21 09:01AM
Oct-12-21 09:15AM
Oct-07-21 12:41PM
Oct-04-21 08:30AM
Sep-28-21 09:15AM
Sep-23-21 09:47AM
Sep-21-21 10:30AM
Sep-17-21 07:40AM
Sep-13-21 08:00AM
Sep-02-21 09:41AM
Aug-31-21 10:00AM
Aug-19-21 11:00AM
Jul-20-21 02:00PM
Jul-13-21 02:30PM
Jul-12-21 10:30AM
Jul-07-21 04:10PM
Jul-06-21 09:44AM
Jul-02-21 09:37AM
Jul-01-21 04:05PM
Jun-30-21 10:03AM
Jun-28-21 09:45AM
Jun-22-21 10:06AM
Jun-15-21 02:14PM
Jun-07-21 08:30AM
May-28-21 10:30AM
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LONDONER KENNETH LChief Executive OfficerJun 13Buy1.2415,60019,3582,507,020Jun 13 03:36 PM
LONDONER KENNETH LChief Executive OfficerJun 12Buy1.176,0007,0402,491,420Jun 12 06:11 PM
LONDONER KENNETH LChief Executive OfficerJun 02Buy1.374,6006,2922,485,420Jun 09 04:07 PM
LONDONER KENNETH LChief Executive OfficerMay 31Buy1.578,00012,5602,480,820Jun 09 04:07 PM